Medicare deploys AI to catch fraud—but beneficiaries may not understand the algorithm
S. 2066 — Medicare Transaction Fraud Prevention Act · Filed by Tim Sheehy (R-MT) · 3 cosponsors · Introduced Jun 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill creates a 2-year pilot program in Medicare that uses artificial intelligence algorithms to score the risk of fraud in claims for durable medical equipment and lab tests on a scale of 1–99. Beneficiaries who opt in will receive alerts when their transactions are flagged as high-risk, and they can respond to dispute the claim; Medicare staff will then review the flagged transaction. The program aims to catch fraudulent billing patterns while giving beneficiaries a chance to verify their own claims are legitimate.
Why we flagged it
The bill's core function is to establish a time-limited AI-driven fraud-detection system for a subset of Medicare claims. It is neither a broad regulatory overhaul nor a narrow carve-out, but a targeted pilot with explicit safeguards and beneficiary opt-in.
What the text implies
- Algorithm training on beneficiary data may create a permanent dataset that outlives the 2-year pilot, with unclear governance over future use or retention.
- The bill permits the Secretary to 'waive or forgo notice' to beneficiaries or providers in some cases, creating a discretionary exception to transparency that is not further defined.
The full analysis lists 5 implications of this text.
Who stands to gain
pharmaceutical companies (reduced fraudulent claims on their products); durable medical equipment suppliers (those with legitimate billing patterns); clinical diagnostic laboratories (those with legitimate billing patterns)